Reimagining end-of-life care: Balancing polypharmacy, treatment modification, and quality of life in advanced cancer patients

Reimagining end-of-life care: Balancing polypharmacy, treatment modification, and quality of life in advanced cancer patients
BNN, by Mahnoor Jehangir; 2/15/24
In a recent groundbreaking study, researchers have illuminated the complexities surrounding polypharmacy and the prescription of potentially inappropriate medications (PIMs) to patients at the end of their lives, particularly those battling advanced cancer. This investigation, involving a cohort of 265 older adults, sheds light on the nuanced challenges and critical decisions faced by healthcare providers in managing the delicate balance between treatment efficacy and quality of life for terminally ill patients.